Cognitive behavioural therapy and medication for treatment of adolescent depression: a network meta-analysis
Recommended Citation
Dardas LA, Xu H, Franklin MS, Scott J, Vance A, van de Water B, and Pan W. Cognitive behavioural therapy and medication for treatment of adolescent depression: a network meta-analysis. Behav Cogn Psychother 2023; 1-16.
Document Type
Article
Publication Date
1-12-2023
Publication Title
Behav Cogn Psychother
Abstract
BACKGROUND: Cognitive behavioural therapy (CBT) and medication are widely accepted and useful interventions for individuals with depression. However, a gap remains in our current understanding of how CBT directly benefits adolescents with depression.
AIMS: The purpose of this study was to examine the short- and long-term effectiveness of CBT only, CBT+Medication, or Medication alone in reducing the duration of major depressive episodes, lessening internalizing and externalizing symptoms and improving global functioning.
METHODS: Data were extracted from 14 unique studies with a total of 35 comparisons. Network meta-analysis was conducted and p-scores, a measure of the extent of certainty that one treatment is better than another, were used to rank treatments.
RESULTS: There was no significant difference between any two treatments for depression, nor internalizing or externalizing symptoms. For global functioning, CBT had significantly greater effect at the longest follow-up than CBT+Medication. CBT+Medication had the highest p-score for depression, short- and long-term effects, and internalizing and externalizing symptoms long-term effects. No indication of publication bias was found.
CONCLUSIONS: Neither modality, CBT nor medication, is superior for treating adolescent depression. However, CBT was superior in improving global functioning, which is essential for meeting developmental goals.
PubMed ID
36632826
ePublication
ePub ahead of print
First Page
1
Last Page
16
